We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

By LabMedica International staff writers
Posted on 31 Mar 2025

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. More...

The fluorescence in situ hybridization (FISH) technique facilitates the swift detection and identification of microbes by leveraging differences in their genomic sequences, without the need for time-consuming culturing or sequencing. However, the growing volume of microbial genomic data has made it increasingly difficult to design appropriate probes for microbial mixtures. Now, a new set of peptide nucleic acid (PNA)-based FISH probes has been developed, offering optimal target specificity by analyzing variations in the 16S ribosomal RNA sequence across bacterial species. Due to their superior ability to penetrate bacteria and higher sensitivity to mismatches, these PNA probes successfully identified seven bacterial species commonly associated with bacteremia with an accuracy ranging from 96% to 99.9% using the optimized FISH technique. Detection is enhanced by Förster resonance energy transfer (FRET) between adjacent binding PNA probes, which prevents cross-reactivity between species. This approach allows for rapid, sequential identification of bacterial species, utilizing chemically cleavable fluorophores, without sacrificing accuracy. Thanks to their exceptional accuracy and speed, these techniques hold significant promise for clinical applications.

A team of researchers from UNIST (Ulsan, Republic of Korea) has developed a diagnostic method capable of identifying infectious pathogens with nearly 100% accuracy in under three hours. This method is far faster and more accurate than traditional bacterial culture and polymerase chain reaction (PCR) analysis, offering potential to reduce mortality rates in critical conditions such as sepsis, where the prompt administration of antibiotics is essential. In their study, published in Biosensors and Bioelectronics, the researchers introduced a new diagnostic approach that uses PNA-based probes to detect pathogens. The FISH technique works by detecting fluorescent signals generated when the probe molecules bind to specific bacterial genetic sequences. This innovative method utilizes two PNA molecules at once, with the researchers designing PNA sequences that specifically target the ribosomal RNA of particular bacterial species by analyzing the genomic sequences of 20,000 species.

PNA exhibits greater sensitivity to sequence mismatches compared to conventional DNA-based probes, and it has superior penetration through bacterial cell walls. Furthermore, the requirement for both PNA molecules to bind to their target site before generating a signal significantly reduces the risk of crosstalk, thereby enhancing accuracy when multiple bacterial strains overlap. In tests, the technology successfully detected seven bacterial species—including E. coli, Pseudomonas aeruginosa, and Staphylococcus aureus—with over 99% accuracy for all species except Staphylococcus aureus, which was detected with an accuracy of 96.3%. The method’s effectiveness was also validated in mixed bacterial samples, where Enterococcus and E. coli were identified with over 99% accuracy when tested together. The research team plans further experiments using blood samples from actual patients to explore the clinical applications of this method.

“This method will aid in the diagnosis of infections requiring immediate antibiotic treatment, such as sepsis, urinary tract infections, and pneumonia, while also helping to reduce unnecessary antibiotic usage,” said Professor Hajun Kim from the Department of Biomedical Engineering at UNIST.

Related Links:
UNIST


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
STI Test
REALQUALITY RQ-SevenSTI
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.